Multicenter, randomized, phase III trial of CD8(+) tumor-infiltrating lymphocytes in combination with recombinant interleukin-2 in metastatic renal cell carcinoma.

Source:http://linkedlifedata.com/resource/pubmed/id/10561318

Download in:

View as

General Info

Authors

Thompson JA, Novick AC, Bukowski RM, Lange P, Vogelzang NJ, Steinberg GD, Figlin RA, Belldegrun AS

PMID
10561318